/Investor DB

APERTURE Venture Partners — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Neuros Medicalneurosmedical.comSeries A · Jul 2025 · $56M

Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.

BiotechHealthtechMedical DevicesAliso Viejo, US

David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in

BoardJoyce Erony(Director)inWilliam Harrington(Director)in

Co-investorsAmzak HealthCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart VenturesRiverVest Venture Partners+5 more

Sound Blade Medicalsoundblademedical.comSeries A · Jan 2025 · $17M

SoundBlade Medical develops handheld histotripsy technology for non-invasive surgery, using focused ultrasound to treat tissue with precision.

HardwareHealthtechMedical Devices

Jeremy Brown(Co-Founder & CTO)inMatt Mallay(Co-Founder & Sr. Dir. R&D)inAndre Bezanson(Co-Founder & Dir. R&D)inEli Vlaisavljevich(Co-Founder)inRick Balys(Co-Founder)inNeil Barman(Chief Executive Officer)in

Co-investorsAmzak HealthLumira VenturesInvest Nova Scotia

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.